SCHEMBL418511

SCHEMBL418511

COC(=O)[C@H]1CCC(OC(=O)N2CCc3ccccc3C2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.47
NOTUM Q6P988 1/20 0.47
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
POLB P06746 2/20 0.44
ABHD6 Q9BV23 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 3/20 0.44
HTT P42858 1/20 0.44
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
TAS1R2 Q8TE23 2/20 0.43
ALDH1A1 P00352 4/20 0.43
TAAR1 Q96RJ0 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16141448 1.00 KEAP1 (0.47) KEAP1NOTUMNPC1RAB9APOLB
SCHEMBL30132306 0.84 NOTUM (0.57) KEAP1NOTUMNPC1RAB9APOLB
SCHEMBL2098678 0.80 ADAM10 (0.49) NOTUMNPC1RAB9APOLBABHD6
SCHEMBL2102200 0.80 NOTUM (0.45) NOTUMNPC1RAB9APOLBABHD6
SCHEMBL8253789 0.80 NOTUM (0.45) NOTUMNPC1RAB9APOLBABHD6
SCHEMBL2608458 0.80 NOTUM (0.45) NOTUMNPC1RAB9APOLBABHD6
SCHEMBL2098781 0.80 ADAM10 (0.49) NOTUMNPC1RAB9APOLBABHD6
SCHEMBL2102201 0.80 NOTUM (0.45) NOTUMNPC1RAB9APOLBABHD6
SCHEMBL7857753 0.80 ADAM10 (0.49) NOTUMNPC1RAB9APOLBABHD6
SCHEMBL416579 0.80 ADAM10 (0.49) NOTUMNPC1RAB9APOLBABHD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8529882-B2 Peptidomimetic protease inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-09-10 US disclosed
US-20120282219-A1 PEPTIDOMIMETIC PROTEASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-11-08 US disclosed
US-20120064034-A1 Peptidomimetic protease inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120064034-A1 Peptidomimetic protease inhibitors CTSC, PREP, PEPD KEAP1 622/4885NOTUM 2135/4885NPC1 674/4885
US-20120282219-A1 PEPTIDOMIMETIC PROTEASE INHIBITORS CTSC, PEPD, PREP KEAP1 1037/4885NOTUM 2186/4885NPC1 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.